The global biopharmaceutical market continues to expand

In recent years, the global biopharmaceutical industry has entered a period of rapid development. According to the latest IQVIA report, global drug expenditures will continue to rise at an average annual compound growth rate of 6.6% from 2024 to 2028, and it is expected that the market size will exceed the $2.2 trillion mark by 2028. As an important pillar of the global raw material supply chain, China carries about one-third of the world's raw material supply, providing broad opportunities for domestic fine chemical enterprises to go global. Changsha Fuzhen Biotechnology has taken advantage of the situation, accelerated its international layout, and actively expanded overseas markets.

Currently, the internationalization process of China's fine chemical enterprises is accelerating, and more and more companies are leveraging their high-quality products and cost advantages to go abroad and participate in global market competition. As a cutting-edge technology enterprise, Changsha Fuzhen Biotechnology is based on its core product advantages, with "high-quality sources, affordable prices, and attentive services" as its core, gradually expanding overseas markets, focusing on Southeast Asia, Europe, America, and other regions, committed to providing high-quality fine chemical products and customized services to global customers.

To meet the needs of international development, Fuzhen Biotechnology strictly optimizes its product quality control system in accordance with international standards, actively connects with international authoritative certification systems such as FDA and EMA, and continuously enhances the international competitiveness of its products. The company's core products, including pharmaceutical intermediates, small molecule compounds, and monoclonal antibody related raw materials, have gained recognition from some overseas customers with stable quality and reasonable prices, gradually opening up new opportunities in the overseas market.

At the same time, Fuzhen Biotechnology has established a specialized overseas service team to optimize cross-border logistics and after-sales service systems, providing efficient and convenient consulting, ordering, logistics, and technical support services for overseas customers, and solving their worries. In addition, the company supports bilingual services in both Chinese and English, adapting to the communication habits of overseas customers, further enhancing customer experience, and laying a solid foundation for international layout.

Industry experts say that internationalization of domestic fine chemical enterprises is an inevitable trend in industry development and an important path for enterprises to achieve high-quality development. The international layout of Fuzhen Biotechnology not only expands market space, but also enhances the company's technological level and brand influence. In the future, with the continuous expansion of overseas markets, Fuzhen Biotechnology will continue to cultivate core technologies, optimize products and services, create an international fine chemical brand, and help China's fine chemical industry go global.